Search Results 2681-2690 of 18383 for Chronic Lymphocytic Leukemia

  1. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB. Rochester, ...

  2. Rituximab Vasculitis Maintenance Study - Clinical Trials

    A diagnosis of AAV [granulomatosis with ... lymphocytes and B-cell lymphomas. The light- and ... lymphoid cell lines, and lyse human target cells ...

  3. A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene - Mayo Clinic

    A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene.

  4. Biological therapy for cancer - Care at Mayo Clinic

    These standards recognize scientific excellence and a multidisciplinary approach to cancer prevention, diagnosis and treatment. Mayo Clinic in Rochester, ...

  5. An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy - Mayo Clinic

    ... Leukemia (AML) Ineligible for Intensive Chemotherapy ... Phase 4 trials look at long-term safety and ... leukemia (AML) for whom experimental therapy is appropriate ...

  6. Commencement Program - Mayo Clinic College of Medicine and Science

    Thesis: The Role of TNF-alpha in Chronic. Lymphocytic Leukemia Hematopoietic. Dysfunction. Position. Postdoctoral Fellow. The University of California Santa ...

  7. Tools To Detect The Effect Of Hypomethylating Agents And Examination Of Protein Interactions Predicting Response To Therapy In Acute Myeloid Leukemia - Mayo Clinic

    ... Leukemia. Print details. Share; Facebook · Twitter ... Acute myeloid leukemia (AML) is a heterogeneous ... long-term outcomes remain poor, especially in ...

  8. A Study of Patients with Polycythemia Vera In US Clinical Practices

    Diagnosis of myelofibrosis (MF) [including primary MF, post-PV MF, or post-essential thrombocythemia MF]; Diagnosis of secondary Acute Myeloid Leukemia ...

  9. Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    ... lymphatic system and bone marrow. In particular, the lab focuses its ... But there is still much to learn about prevention, diagnosis, treatment, and survivorship ...

  10. CardiovascularUpdate

    the treatment of chronic myelogenous leukemia. ... female who received daunorubicin-based chemotherapy for acute lymphocytic ... To put this data into perspective,.